Security key
98973P309
Alaunos Therapeutics, Inc. - Common stock (TCRT)
CUSIP: 98973P309
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common stock
- Total 13F shares
- 72,015
- Total 13F value
- $136,970
- Share change
- -120,046
- SEC-reported price per share
- $1.90
- Number of holders
- 28
- Value change
- -$361,475
- Number of buys
- 7
- Number of sells
- 17
- Shares outstanding
- 2,198,384
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
28
Top holders
10
TCRT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Alaunos Therapeutics, Inc. SEC filings
Alaunos Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98973P309
Recent filing periods:
Ownership snapshot
Top reported holders of TCRT - Alaunos Therapeutics, Inc. - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MSD Partners, L.P.
Disclosed value leader
MSD Partners, L.P.
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
Lead comparable stake: 4.6%
Showing 1-6 of 15 holder rows.
Quick read
MSD Partners, L.P. leads the comparable SEC ownership view at 4.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MSD Partners, L.P.'s linked filing trail.
Comparable ownership
Top 5
MSD Partners, L.P.
4.6%
VANGUARD GROUP INC
2.1%
BlackRock, Inc.
1%
GEODE CAPITAL MANAGEMENT, LLC
0.74%
MORGAN STANLEY
0.06%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MSD Partners, L.P. |
13F
Company
|
4.6%
|
$325,252
101,010 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
2.1%
|
$149,195
45,348 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
1%
|
$71,590
22,233 shares
|
— | 30 Sep 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.74%
|
$53,746
16,333 shares
|
— | 30 Sep 2024 |
| MORGAN STANLEY |
13F
Company
|
0.06%
|
$4,305
1,337 shares
|
— | 30 Sep 2024 |
| UBS Group AG |
13F
Company
|
0.05%
|
$3,310
1,028 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
28
Shares
72,015
Rows available
28
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
28
Q4 2024 holders
28
Holder diff
0
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend